| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |